Growing pains in the Medtronic-Kyphon merger

When Medtronic Inc. announced in July 2007 that it was buying a competitor called Kyphon Inc. for $4.2 billion, executives described the deal as a coming-together of complementary technologies for spine surgery to help more patients with crippling back pain.

On paper, the merger of a fast-growing and entrepreneurial firm with a muscular market leader seemed to make solid business sense.

But the potential rewards of the deal — one of the biggest in Medtronic’s history — have yet to be fully realized for the Fridley-based medical technology giant. As Medtronic CEO Bill Hawkins said in a February conference call with Wall Street analysts: “Kyphon, very candidly, has been a bit of a disappointment for us.”


Print Friendly, PDF & Email

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button